Concepedia

Adele M. Alchahin

AM

5

Publications

199

Citations

5

H-Index

2017

Active since

Affiliations

Harvard Stem Cell Institute(Current)

Massachusetts General Hospital

Harvard University

Karolinska Institutet

Adele M. Alchahin is an author at Harvard Stem Cell Institute specializing in pathology, cancer metabolism, and tumor biology.

Top concepts

Publications per year

2017–2024

5

Publications

5

A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma

Adele M. Alchahin, Shenglin Mei, Taghreed Hirz et al. · Nature Communications · 2022 · 77 citations · Full text

Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions

Shenglin Mei, Adele M. Alchahin, Youmna Kfoury et al. · Genome Medicine · 2024 · 47 citations · Full text

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma

Thale Kristin Olsen, Cecilia Dyberg, Bethel Tesfai Embaie et al. · JCI Insight · 2022 · 37 citations · Full text

, , +15

16p11.2 deletion syndrome mice perseverate with active coping response to acute stress – rescue by blocking 5‐<scp>HT</scp>2A receptors

Chris M. Panzini, Daniel G. Ehlinger, Adele M. Alchahin et al. · Journal of Neurochemistry · 2017 · 23 citations · Full text

Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature

Shenglin Mei, Adele M. Alchahin, Bethel Tesfai Embaie et al. · JCI Insight · 2024 · 15 citations · Full text

Rows per page

1–5 of 5